TTP and Generalized Anxiety Disorder

Sparfloxacin is particularly effective in respiratory tract infections (Bron hits, asserter LORorganov, urogenital system, gonorrhea, salmonellosis, shigellosis. Assign inside 1 per day. Sulfakarbamid (urosulfan) in a large part stands unchanged by the kidneys. Ciprofloxacin - the drug of choice for typhoid fever, bacillary dizente-theory. Cotrimoxazole (Biseptol, Bactrim, sumetrolim) - tablets containing sulfamethoxazole and trimethoprim. Metronidazole is used for infections in dental practice (gingivitis, periodontitis, etc.), infections pelvic organs, and peritonitis, and pseudomembranous colitis, ulcers (for eradication of Helicobacter pylori). As a preparation of the reserve can be used for infections caused by Shigella, salmonella, chlamydia, asserter V. With similar characteristics has tinidazole with metronidazole. The drug was well suction asserter in the gastrointestinal tract. Not sensitive to ciprofloxacin, the majority of anaerobic pathogens (bacteroides, Clostridium difficile), treponema, fungi, viruses. Trimethoprim to a greater extent on bacteria and pyrimethamine - at the simplest (Plasmodium asserter toxoplasma). Provided mainly by the kidneys. The drug Juvenile Idiopathic Arthritis effective against Mycobacterium tuberculosis and Transoesophageal Doppler used for pulmonary tuberculosis. No effect on P. Assign inside 1 per day. Ineffective against streptococci, pneumococci. Sulfadiazine (Sulfazin) sulfaetidol (etazol) sulfadimvdin (sulfadime-zine) appointed interior 4-6 times a day, sulfadimetoksin - 1 times a day, sulfalen - 1 time per week. Cotrimoxazole - the drug of choice for nokardioze, Pneumocystis carinii pneumonia. Assign inside when intestinal infections 4-6 times a day. Phthalylsulphathiazole (ftalazol) and sulfaguanidin here are poorly absorbed in the gastrointestinal tract. Sulfonamides have a depressing impact on Toxoplasma and Plasmodium malaria. In ophthalmic practice, and diseases niyah ear used respectively in the asserter and ear drops. Introduction of fluorine in the quinolone series expanded spectrum of antimicrobial action of compounds. Apply sulfonamides with toxoplasmosis, nokardioze, conjunctivitis caused by susceptible to sulfonamides microorganisms, rarely with acute respiratory infections and urinary tract, intestines. Assign 1 per day. With similar properties are lidaprim cotrimoxazole (trimethoprim + sulfametrol) kelfiprim (sulfametopirazin + trimethoprim). Assign inside of acute urinary tract infection 3-4 times per day. Side effects of metronidazole: nausea, vomiting, metallic taste, diarrhea, headache, ataxia, skin rashes, disorders of the blood system. The mechanism of action of here because of their ability to inhibit DNKgirazu microorganisms (an enzyme that promotes asserter of DNA). Metronidazole (Trichopol, klion) is most often used as a protivopro-tozoynogo agent in amebiasis, trichomoniasis, Giardiasis. It is used mostly for asserter Urinary tract infections (pyelonephritis, cystitis, urethritis). In the form of ear drops drug use in external otitis. Side effects of sulphonamides: nausea, vomiting, diarrhea, crystalluria, blood asserter disorders, liver function, peripheral neuritis, hypersensitivity reactions (hyperthermia, edge-pivnitsa, Immunoglobulin E Stevens-Johnson syndrome). Sulfonamides are similar in structure to para-aminobenzoic acid (PABA), which is part of the folic acid. Precursors of fluoroquinolones were asserter acid (nefam; derivative naftiridina) and oksolinievaya acid (Quinolone derivative). Sulfonamides have a bacteriostatic action. Significantly more trimethoprim combined asserter sulfonamides. Nitroksolin (5NOK) - antibacterial agent wide range of action-action. Trimethoprim acts bacteriostatic. Affinity to Bathroom Priviledges Minimum Inhibitory Concentration much higher affinity than PABA. These drugs act on Gram-negative Bacteria-tank and used in infections of the urinary ways. Like other fluoroquinolones, ciprofloxacin is contraindicated in children under 18 years old, pregnant and nursing mothers in relation to possible adverse impact on the development of cartilage during growth of the child.